The Prognostic Impact of Supraclavicular Lymph Node Metastases in Lung Cancer: Do We Need a Modification of the Current Staging System?

Volume 27, Issue 4, April 2026, Pages 1295-1302

Ahmed Sohaib; Hany F. Sedeek; Mahmoud El Madawie; Naglaa Said Elabd; Usama Abouelhassan; Mohamed Alhefny

• View Article
• PDF 482.64 K

Metabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds, with in silico Validation for Non-Small Cell Lung Cancer Therapy

Volume 27, Issue 3, March 2026, Pages 955-965

Roihatul Mutiah; Ermin Rachmawati; Imam Taufik; Alvi Milliana; Riza Ambar Sari; Nabila Rahmadani; Fitriyani Fitriyani

• View Article
• PDF 2.06 M

A Crosstalk between the Receptor Tyrosine Kinase-Like Orphan Receptors ROR1/2 and S1P Signaling Pathways in Lung Cancer

Volume 25, Issue 3, March 2024, Pages 725-733

Rajeev Nema; Ritu Pandey; Ashok Kumar

• View Article
• PDF 1.54 M

Non-Small Cell Lung Cancer: Targetable Variants in Concurrent Tissue and Liquid Biopsy Testing in a North Indian Cohort

Volume 24, Issue 10, October 2023, Pages 3467-3475

Radha Paturu; Raghavendra Lingaiah; Niraj Kumari; Shalini Singh; Narendra Krishnani; Shreya Srivastava; Saima Haleem Siddiqui; Alok Nath

• View Article
• PDF 819.87 K

Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers

Volume 23, Issue 6, June 2022, Pages 1893-1900

Thao Phuong Bui; Phuong Lan Le; Linh Thi Tu Nguyen; Le Trung Tho; Thai Hong Trinh

• View Article
• PDF 2.96 M

Micro RNA-148a Targets Bcl-2 in Patients with Non-Small Cell Lung Cancer

Volume 22, Issue 6, June 2021, Pages 1949-1955

Ghada Nabil Elnaggar; Niveen M El-Hifnawi; Abeer Ismail; Maha Yahia; Reham A A Elshimy

• View Article
• PDF 368.73 K

In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56

Volume 21, Issue 8, August 2020, Pages 2297-2306

Leana Rich M Herrera

• View Article
• PDF 1.46 M

Sequential Administration of EGFR-TKI and Pemetrexed Achieved a Long Duration of Response in Advanced NSCLC Patients with EGFR-mutant Tumours

Volume 20, Issue 8, August 2019, Pages 2415-2420

Chen Yue-Yun; Hong Ye; Fu Yang; Li Qing; Lin Pan-Pan; Ding Zhen-Yu

• View Article
• PDF 508.35 K

Clinicopathological Significance of MTA 1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis

Volume 18, Issue 11, November 2017, Pages 2903-2909

Wei Zhu; Guixian Li; Haina Guo; Honglong Chen; Xiujuan Xu; Jiali Long; Chao Zeng; Xiaojun Wang

• View Article
• PDF 634.38 K

The Prognostic Value of Pre-Treatment Leukocytosis in Patients with Previously Treated, Stage IIIB/IV Non-Small Cell Lung Cancer Treated with the IGF-1R Pathway Modulator AXL1717 or Docetaxel; a Retrospective Analysis of a Phase II Trial

Volume 18, Issue 6, June 2017, Pages 1555-1560

Georg Holgersson; Michael Bergqvist; Jonas Nilsson; Marcus Thuresson; Johan Harmenberg; Stefan Bergstrom

• View Article
• PDF 549.94 K

Low-dose Epidermal Growth Factor Receptor (EGFR)- Tyrosine Kinase Inhibition of EGFR Mutation-positive Lung Cancer: Therapeutic Benefits and Associations Between Dosage, Efficacy and Body Surface Area

Volume 17, Issue 2, February 2016, Pages 785-789

• View Article
• PDF 451.7 K

Correlation between EGFR Gene Mutations and Lung Cancer: a Hospital-Based Study

Volume 16, Issue 16, December 2015, Pages 7071-7076

• View Article
• PDF 888.23 K

Systematic Analysis of Icotinib Treatment for Patients with Non-Small Cell Lung Cancer

Volume 16, Issue 13, December 2015, Pages 5521-5524

• View Article
• PDF 335.8 K

Current Drugs and Drug Targets in Non-Small Cell Lung Cancer: Limitations and Opportunities

Volume 16, Issue 10, October 2015, Pages 4147-4156

• View Article
• PDF 990.57 K

Upregulation and Clinicopathological Significance of Long Non-coding NEAT1 RNA in NSCLC Tissues

Volume 16, Issue 7, July 2015, Pages 2851-2855

• View Article
• PDF 892.26 K

Prognostic Impact of Elevation of Vascular Endothelial Growth Factor Family Expression in Patients with Non-small Cell lung Cancer: an Updated Meta-analysis

Volume 16, Issue 5, May 2015, Pages 1881-1895

• View Article
• PDF 896.94 K

Rs895819 within miR-27a Might be Involved in Development of Non Small Cell Lung Cancer in the Chinese Han Population

Volume 16, Issue 5, May 2015, Pages 1939-1944

• View Article
• PDF 510.93 K

Screening for Patients with Non-small Cell Lung Cancer Who Could Survive Long Term Chemotherapy

Volume 16, Issue 2, February 2015, Pages 647-652

• View Article
• PDF 454.54 K

Outcome of Daily Cisplatin with Thoracic Chemoradiotherapy in Advanced Non-small Cell Lung Cancer Patients with Comorbid Disorders: a Pilot Study

Volume 15, Issue 20, December 2014, Pages 8591-8594

• View Article
• PDF 400.85 K

Safety of Brucea javanica and Cantharidin Combined with Chemotherapy for Treatment of NSCLC Patients

Volume 15, Issue 20, December 2014, Pages 8603-8605

• View Article
• PDF 391.97 K

Distribution of EGFR Mutations Commonly Observed in Primary Lung Adenocarcinomas in Pakistan as Predictors for Targeted Therapy

Volume 15, Issue 17, December 2014, Pages 7125-7128

• View Article
• PDF 752.95 K

TGF-β1 Protein Expression in Non-Small Cell Lung Cancers is Correlated with Prognosis

Volume 15, Issue 19, December 2014, Pages 8143-8147

• View Article
• PDF 1.01 M

Expression of Hypoxia-inducible Factor Prolyl Hydroxylase 3 HIFPH3 in Human Non-small Cell Lung Cancer (NSCLC) and Its Correlation with Prognosis

Volume 15, Issue 14, December 2014, Pages 5819-5823

• View Article
• PDF 516.07 K

Efficacy of First-line Chemotherapy Affects the Second-Line Setting Response in Patients with Advanced Non-Small Cell Lung Cancer

Volume 15, Issue 16, December 2014, Pages 6799-6804

• View Article
• PDF 577.63 K

Association between a p73 Gene Polymorphism and Genetic Susceptibility to Non-small Cell Lung Cancer in the South of China

Volume 15, Issue 23, December 2014, Pages 10387-10391

• View Article
• PDF 595.65 K